Molecular Research for Breast Cancer
Submission Deadline: 31 Jan 2023
Guest Editor

School of Nutrition and Health Sciences, Taipei Medical University, Taiwan
Interests: nutrition; food sciences; nutraceutical; dietary supplemants; dysmenorrhea; endometriosis; female cancers; uterine leiomyoma
Special Issue in IMR Press journals
Special Issue in Nutrition in Gynecologic Oncology
Special Issue Information
Dear Colleagues,
The incidence and mortality of breast cancer rank first among gynecological tumors worldwide. Early detection, timely diagnosis and tailored management have become critical steps in the treatment of breast cancer. Many studies have used chemotherapeutics or molecularly targeted therapy to reduce cancer progression by targeting specific mutated genes in breast cancer patients along with consideration of the factors that make breast cancer worse. However, there are many patients whose therapeutic effects are mitigated due to adverse reactions from side effects of the drugs utilized. Natural products can assist current chemotherapeutic agents and achieve therapeutic effects at lower doses. Advantages are not only to inhibit the growth of malignant tumors at a dose that is harmless to normal tissues, but also to improve many symptoms derived from the disease in combination with the efficacy of the natural products themselves. Therefore, exploring the molecular mechanism of adjuvant therapy using various natural products is the focus of this special topic.
This Special Issue encourages interested researchers to provide abstracts and ensure compliance with the scope of this issue before submitting manuscripts.
This Special Issue will cover topics including:
- The efficacy of natural products on breast cancer
- The impact of nutrients on breast cancer treatment
- Molecular mechanisms involved in the treatment of breast cancer with natural products
- Molecular mechanism of natural products for adjuvant chemotherapeutics
Prof. Shih-Min Hsia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (2)
Kaempferol Improves Breast Cancer-Related Depression through the COX-2/PGE2 Pathway
Front. Biosci. (Landmark Ed) 2023, 28(11), 311; https://doi.org/10.31083/j.fbl2811311
(This article belongs to the Special Issue Molecular Research for Breast Cancer)
Photodynamic Therapy of Breast Cancer in Animal Models and Their Potential Use in Clinical Trials—Role of the Photosensitizers: A Review
Front. Biosci. (Landmark Ed) 2023, 28(7), 144; https://doi.org/10.31083/j.fbl2807144
(This article belongs to the Special Issue Molecular Research for Breast Cancer)
